Karuna Therapeutics Inc. (KRTX) Misses Q3 EPS by 44c
Tweet
Share
E-mailGet Alerts KRTX Hot Sheet
Join SI Premium – FREE
Karuna Therapeutics Inc. (NASDAQ: KRTX) reported Q3 EPS of ($3.16), $0.44 worse than the analyst estimate of ($2.72).
For earnings history and earnings-related data on Karuna Therapeutics Inc. (KRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- CalPrivate Bank names Andra Frazier as chief credit officer
- The LGL Group (LGL) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
